Blood Tests Biomarkers Laboratory Testing Molecular Diagnostics Point-of-Care Testing Laboratory Tests In Vitro Diagnostics Laboratory Services Cancer Screening Early Detection Imaging Techniques Genetic Testing Non-invasive Testing In-vitro Diagnostics Non-invasive Procedures Imaging Testing Methods Rapid Testing Cancer Detection Cancer Diagnostics Precision Medicine Blood Test Diagnostic Tests Market Dynamics Laboratory Acquisitions Rapid Tests Disease Testing Affordable Healthcare PCR Testing Cancer Research Core Laboratory Diagnostics Noninvasive Screening Biotechnology Antibody Testing Lung Diagnostics ADHD Diagnosis Non-invasive Techniques Personalized Medicine Diagnostic Platforms Health Testing Kidney Function Tests Clinical Applications Chronic Disease Prediction Imaging Technology Rare Diseases Neurology In-Vitro Diagnostics Laboratories Disease Diagnosis Cancer Global Diagnostics Outpatient Care Market Trends Medical Research Lucid Diagnostics Neurological Assessments Microbiome Testing Sepsis Diagnosis Veterinary Medicine Radiodiagnostics Testing Medical Tests Clinical Testing Laboratory Techniques Disease Detection Predictive Diagnostics Pathology Medical Technology Non-Invasive Testing Medical Equipment Urine Tests Non-invasive Technologies COVID-19 Testing Biosensing Technologies Molecular Testing Antimicrobial Resistance Prediction Biomarker Detection Proteomics Medical Testing
Management signals a reset built on new product launches and the LEX platform to revive growth.
